Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.56 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.56 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.56 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.49 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19583243 | 0.86 | MAPT (0.57) | CYP2D6ADRB2ADRB1ADRB3MAPT | |
| SCHEMBL6630532 | 0.85 | MAPT (0.64) | CYP2D6ADRB2ADRB1ADRB3MAPT | |
| SCHEMBL6630527 | 0.82 | CYP2D6 (0.58) | CYP2D6ADRB2ADRB1ADRB3MAPT | |
| SCHEMBL6553912 | 0.82 | CYP2D6 (0.61) | CYP2D6ADRB2ADRB1ADRB3MAPT | |
| Methacrylic Acid SCHEMBL28914843 | 0.82 | LMNA (0.57) | CYP2D6ADRB2ADRB1ADRB3MAPT | |
| SCHEMBL1027989 | 0.79 | MTNR1A (0.51) | MAPTALDH1A1KMT2ASMN1; SMN2MTNR1A | |
| SCHEMBL14783698 | 0.78 | CYP2D6 (0.54) | CYP2D6ADRB2ADRB1ADRB3MAPT | |
| SCHEMBL11040659 | 0.78 | LMNA (0.50) | CYP2D6ADRB2ADRB1ADRB3MAPT | |
| SCHEMBL7096059 | 0.78 | CYP2D6 (0.56) | CYP2D6ADRB2ADRB1ADRB3MAPT | |
| SCHEMBL219561 | 0.77 | MAPT (0.51) | CYP2D6ADRB2ADRB1ADRB3MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12226545-B2 | Micro injectable, low chromatic aberration intraocular lens materials | BENZ RESEARCH AND DEVELOPMENT CORP (US) | 2025-02-18 | — | — | US | disclosed |
| US-20250032398-A1 | HIGH MOLECULAR WEIGHT BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES AND HYDROPHILIC MONOMERS, COMPOSITIONS, AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2025-01-30 | — | — | US | disclosed |
| CN-110462448-B | Hydrophilic material with high refractive index | 宾视研发公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-110891618-B | Microinjectable, low color aberration intraocular lens materials | 宾视研发公司 | 2023-01-03 | — | — | CN | disclosed |
| US-20220389245-A1 | METAL OXIDE NANOPARTICLES | BASF SE (DE) | 2022-12-08 | — | — | US | disclosed |
| US-20220249737-A1 | MICRO INJECTABLE, LOW CHROMATIC ABERRATION INTRAOCULAR LENS MATERIALS | BENZ RESEARCH AND DEVELOPMENT CORP. (US) | 2022-08-11 | — | — | US | disclosed |
| EP-3555677-B1 | HIGH REFRACTIVE INDEX HYDROPHILIC MATERIALS | BENZ RES AND DEVELOPMENT CORPORATION (US) | 2022-04-20 | — | — | EP | disclosed |
| CN-109475660-B | Hydrophobic intraocular lenses | 宾视研发公司 | 2022-03-22 | — | — | CN | disclosed |
| US-11274219-B2 | Surface functionalized titanium dioxide nanoparticles | BASF SE (DE) | 2022-03-15 | — | — | US | disclosed |
| EP-3458118-B1 | HYDROPHOBIC INTRAOCULAR LENS | BENZ RES AND DEVELOPMENT CORPORATION (US) | 2021-10-27 | — | — | EP | disclosed |
| WO-2018132548-A1 | CROSS-LINKED BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES, COMPOSITIONS, AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2018-07-19 | — | — | WO | disclosed |
| US-20180169296-A1 | HIGH REFRACTIVE INDEX HYDROPHILIC MATERIALS | BENZ RESEARCH AND DEVELOPMENT CORP. (US) | 2018-06-21 | — | — | US | disclosed |
| WO-2018112180-A1 | HIGH REFRACTIVE INDEX HYDROPHILIC MATERIALS | BENZ RESEARCH AND DEVELOPMENT CORP. (US) | 2018-06-21 | — | — | WO | disclosed |
| WO-2017200934-A1 | HYDROPHOBIC INTRAOCULAR LENS | BENZ RESEARCH AND DEVELOPMENT CORP. (US) | 2017-11-23 | — | — | WO | disclosed |
| US-20170327615-A1 | HYDROPHOBIC INTRAOCULAR LENS | BENZ RESEARCH AND DEVELOPMENT CORP. (US) | 2017-11-16 | — | — | US | disclosed |
| US-20170027685-A1 | HYDROPHOBIC INTRAOCULAR LENS | BENZ RESEARCH AND DEVELOPMENT CORPORATION (US) | 2017-02-02 | — | — | US | disclosed |
| US-9381080-B2 | Hydrophobic intraocular lens | BENZ RESEARCH AND DEVELOPMENT CORP. (US) | 2016-07-05 | — | — | US | disclosed |
| EP-2756014-A1 | HYDROPHOBIC INTRAOCULAR LENS | Benz Research And Development Corporation (US) | 2014-07-23 | — | — | EP | disclosed |
| US-20130253159-A1 | HYDROPHOBIC INTRAOCULAR LENS | BENZ RESEARCH AND DEVELOPMENT CORP. | 2013-09-26 | — | — | US | disclosed |
| WO-2013040434-A1 | HYDROPHOBIC INTRAOCULAR LENS | BENZ RESEARCH AND DEVELOPMENT CORP. (US) | 2013-03-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250032398-A1 | HIGH MOLECULAR WEIGHT BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES AND HYDROPHILIC MONOMERS, COMPOSITIONS, AND APPLICATIONS THEREOF | PCNA, ADSL, APH1B | CYP2D6 3796/4885ADRB2 3925/4885ADRB1 3207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.